Venture startup

Who invested in Galileo Genomics

2 rounds we have observed, with the 4 investors named in them. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.

Funding summaryUpdated 26 Oct 2026

$15Mraised across 2 rounds since 2002, from 2 sources

$6.5MVenture$9.0MVenture
Latest round
Venture, $9.0MJan 2004
Step-upi
1.4×
Investors
4
See who backed them

The funding story

Each circle is a round, placed by date and sized by amount. The line above is the running total.

20032004
$6.5MVenture$9.0MVenture
First round
Venture, $6.5M
Aug 2002
Biggest round
$9.0M
Venture · Jan 2004
Between rounds
17 months
from the last two

The rounds

  1. Jan 2004
    Venture$9.0M3 new1 returning

    From a historical funding record

  2. Aug 2002
    Venture$6.5M1 new

    From a historical funding record

Who was in which round

The busiest backers across the latest rounds. A filled square is a round they joined; a dark one, a round they led.

Everyone who backed them

BioFund ManagementVC firm2rounds
HBM BioVenturesGrowth equity1round
CarnegieHedge fund1round

Missing a round, or an investor who was in one? Tell us.

Quick answers about Galileo Genomics

Who invested in Galileo Genomics?

Galileo Genomics's investors include BioFund Management, HBM BioVentures, MVI (MENA Venture Investments) and Carnegie.

How much has Galileo Genomics raised?

Galileo Genomics has raised $15M across 2 rounds since 2002.

When did Galileo Genomics last raise?

Galileo Genomics's most recent round was a Venture of $9.0M in Jan 2004.

What was Galileo Genomics's biggest round?

Its most recent round, $9.0M in Jan 2004, is also its largest on record.

Who backed Galileo Genomics first?

Galileo Genomics's first round on record, in Aug 2002, was backed by BioFund Management.

What stage is Galileo Genomics at?

Galileo Genomics's latest named round is a Venture, in Jan 2004.

Find investors like these

Search every investor by what they have actually funded, then narrow to your stage and market. Free.